GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, knock-in mouse, point-mutation mouse, transgenic mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.
Frequently asked questions
What sector does Gempharmatech Co. Ltd. A (688046) operate in?
Gempharmatech Co. Ltd. A belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Gempharmatech Co. Ltd. A (688046) current stock price?
As of the latest data, Gempharmatech Co. Ltd. A stock price is CN¥37.94, with a previous close of CN¥34.98. Gempharmatech Co. Ltd. A gained CN¥2.96 in the last trading session, representing a 8.46% increase.
What is Gempharmatech Co. Ltd. A (688046) current market capitalization?
Gempharmatech Co. Ltd. A market cap is approximately 15.56 billion.
What is Gempharmatech Co. Ltd. A (688046) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.45, and the forward EPS is CN¥0.62.
What is Gempharmatech Co. Ltd. A (688046) Price-to-Earnings (P/E) ratio?
Gempharmatech Co. Ltd. A current P/E ratio is 84.31, with a forward P/E of 61.69.
Does Gempharmatech Co. Ltd. A (688046) pay dividends?
Yes. Gempharmatech Co. Ltd. A pays semiannual dividends with an annualized yield of 1% and an estimated annual payout of CN¥0.38 per share.
When is the next ex-dividend date for Gempharmatech Co. Ltd. A (688046)?
The next ex-dividend date is scheduled for December 09, 2026.
What is Gempharmatech Co. Ltd. A (688046) beta (volatility) score?
Gempharmatech Co. Ltd. A has a beta of 0.897, meaning its volatility is roughly in line with the market.
